Deferoxamine Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 500 mg/mL

Reference Brands: Desferal(US)

Category: Blood Disorder

Deferoxamine binds to excess iron, forming a stable complex that is excreted in urine and feces. It effectively treats iron overload from transfusions and iron poisoning, preventing organ damage. Benefits include rapid reduction of iron levels, protection against toxicity, and improved patient outcomes in iron accumulation conditions. Deferoxamine Injection is available in Injection and strengths such as 500 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Deferoxamine Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Deferoxamine Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Deferoxamine injection, marketed as Desferal, is approved in the US by the FDA and in the EU via EMA for treating iron overload and poisoning. Regulatory approval requires a detailed dossier including clinical safety, efficacy, manufacturing, and pharmacovigilance data. In the US, submission to the FDA involves comprehensive review, while in the EU, EMA guidelines ensure quality and safety standards are met. For expert guidance on dossier development, regulatory pathways, and successful market access, visit PharmaTradz. Ensuring compliance with regional regulations is essential for the safe and effective use of deferoxamine injection worldwide, supporting patients with iron overload conditions.